Clinical Management of Obesity

Table of Contents

1 EXECUTIVE SUMMARY

• Scope and Methodology
  • Scope and Segmentation
  • Methodology
• Key Findings
  • An Overview of the Weightloss Industry
  • Noteworthy Technology Developments--Companies
  • Noteworthy Technology Developments--Universities

2 CLINICAL MANAGEMENT OF OBESITY--TECHNOLOGY ANALYSIS

• Obesity--Overview
  • Definitions
  • Causes and Associated Health Problems
• Technology Primer
  • Diet Therapy and Lifestyle Changes
  • Pharmacotherapy
  • Bariatric Surgery
  • Medical Devices
  • Technology Impact Analysis and Future Trends

3 TECHNOLOGY ADOPTION FACTOR ANALYSIS

• Pharmacotherapy
  • Technology Accelerators
  • Technology Roadblocks
• Medical Devices
  • Technology Accelerators
  • Technology Roadblocks
• Bariatric Surgeries
  • Technology Accelerators
  • Technology Roadblocks
• Funding Analysis; Collaborations and Mergers
  • Companies
  • Universities and Government Institutions
  • Collaborations and Mergers

4 ADVANCEMENTS IN CLINICAL MANAGEMENT OF OBESITY

• Technology Innovations in Companies--North America
  • A Novel Antiobesity Drug Suppresses Appetite through Inhibition of Serotonin Reuptake--USA
  • A Novel Appetite Suppressant Selectively Inhibits Cannabinoid Receptors--USA
  • A Novel Small Molecule for the Treatment of Obesity--USA
  • A Natural Peptide Hormone Suppresses Appetite and Enhances Metabolic Rate--USA
  • Ghrelin Receptor Modulators Offer Potential Obesity Treatment Options--Canada
  • Neurostimulation Technique to Treat Chronic Obesity--USA
  • A Novel Small Molecule Drug to Treat Obesity--USA
  • A Unique and Selective Hydroxy Tryptamine Receptor Agonist to Treat Obesity--USA
  • A Novel and Selective Hydroxy Tryptamine Receptor Agonist for Obesity Treatment--USA
  • A Novel Technology Leads to Apoptosis of Fat Cells--USA
  • Adjustable and Reversible Gastric Banding Technique to Treat Morbid Obesity--USA
• Technology Innovations in Companies--Europe
  • Antiobesity Drug Works by Blocking Fat Absorption--UK
  • Potent and Selective Cannabinoid Receptor Antagonists as Novel Antiobesity Agents--UK
  • A Novel Single Peptide Drug with a Dual Receptor Agonist Action to Treat Obesity--Denmark
  • A Novel Antiobesity Drug Targets Thyroid Hormone Receptors--Sweden
  • A Natural Appetite Suppressant from Korean Pine Nuts--Netherlands
  • A Unique Gastro Intestinal Lipase Inhibitor Aids Weight Loss--UK
  • A Novel Vaccine Treats Obesity by Induction of Ghrelin Specific Antibodies--Switzerland
• Technology Innovations in Companies--APAC
  • A Novel Peptide-Based Drug to Treat Obesity--Australia
  • Potential Obesity Therapies through the Prevention of Adipogenesis--Australia
  • A Pan Peroxisome Proliferator-Activated Receptor Agonist Burns Fat--India
  • Cannabinoid Receptor Antagonist Drug Therapy for Obesity and Related Disorders--India
  • A Potential Antiobesity Drug Inhibits Alpha-Amylase--India
• Technology Innovations in Universities--World
  • Hormone Discovery Offers Hope for Obesity Drug--USA
  • Stomach Hormone Controls Appetite--UK
  • Study Finds Effect of Dietary Calcium on Weightloss--Denmark
  • Research Finds Relationship between Metabolism and Appetite Suppression--Australia
  • Study Shows the Effect of Second Messenger Molecule on Satiety--UK

5 PATENTS AND KEY CONTACTS

• Patents
  • US Patents--2006
  • US Patents--2004 to 2005
• Key Contacts
  • Company Contacts
  • University Contacts

6 FROST AND SULLIVAN 2006 SCIENCE AND TECHNOLOGY AWARDS

• Excellence in Technology Award
  • Award Description
  • Award Recipient
• Product Innovation Award
  • Award Description
  • Award Recipient
• Excellence in Research Award
  • Award Description
  • Award Recipient

7 DECISION SUPPORT DATABASE

• Healthcare and Pharmaceutical Expenditure--World
  • Total Healthcare Expenditure--World (1996 to 2006)
  • Government Healthcare Expenditure--World (1996 to 2006)
  • Private Healthcare Expenditure--World (1996 to 2006)
  • Pharmaceutical R&D Expenditure--World (1996 to 2006)
• Healthcare Infrastructure--World
  • No. of Hospitals--World (1996 to 2006)
  • No. of Physicians--World (1996 to 2006)
  • No. of Pharmacists--World (1996 to 2006)
• Pervalence of Obesity-Related Health Risks--World
  • Prevalence of Diabetes--World (1996 to 2006)
  • Prevalence of Hypertension--World (1996 to 2006)
  • Incidence of Stroke--World (1996 to 2006)
  • Prevalence of Coronary Heart Disease--World (1996 to 2006)